Jason Hope: Hope for the Future of the Human Race

Jason Hope, as his name implies, is giving the gift of hope for the future of the human race. As a native of Arizona and an entrepreneur,who is giving back to society. Through his philanthropy, he has supported anti aging research, a cause that he is deeply involved with. He is committed to reducing the amount of people has given a substantial amount of money to the SENS Foundation to pioneer research and develop therapies to reduce the amount of people afflicted with chronic diseases occurring with advanced age.

In an effort to be proactive and to make a positive impact, Jason has teamed up with a well known researcher, Aubrey de Grey, Ph.D., who is the founder of the SENS Foundation, a non-profit organization dedicating his life to conducting anti-aging research. Dr. de Grey is a well known scientist in the field of aging and also the chief science officer of the foundation. He has championed the concept of rejuvenation therapy. His research is innovative and groundbreaking in slowing down the aging process in the future.

Dr. de Grey theorizes that aging is the accumulation of damage within the body that is caused by the normal process of metabolism through the span of one’s life. This damage builds up until it meets or exceeds a threshold where it will begin to cause the onset of chronic diseases such as diabetes type 2, hypertension, atherosclerosis, chronic joint pain, Alzheimer’s disease, Parkinson’s disease and cancer. de Grey believes that the only sensible way to decrease the number of people being diagnosed with chronic conditions and diseases is to repair the damage on a regular basis throughout one’s life and will slow down the aging process and add at least 30 years of healthy life.

References: cityscene.org/jason-hope-the-entrepreneur-from-arizona/

Why Talkspace is So Popular with the Public

If you have ever gone to see a regular therapist and have not had much success with this type of care, you need a better way to receive help and advice. In the past, your only option for therapy was to make an appointment, sit on a wait list for weeks or even months and then figure out a way to drive to the office where you’re sitting in front of a stranger spilling your life’s story. It isn’t exactly the best option for everyone, and this is why a company known as Talkspace was launched several years ago. It has become a leader in the world of therapy because it essentially brings your therapy sessions into your own home.

The most important thing to know about Talkspace is that it is incredibly affordable, no matter what your insurance is like. Many people do not have health insurance, and having to afford regular therapy in the past has been a literal nightmare. With Talkspace, you’re only spending a few bucks a day to gain full 24/7 access to a professional and fully licensed therapist. You can be sure you’re talking to a professional who is experienced and educated in their field, and many people find that the therapists through Talkspace are actually better than ones they’ve gone to see locally.

There are so many reasons to consider using Talkspace, and it takes just a few minutes to download onto a device that you use regularly. You can then text your therapist at virtually any time that you want, both day and night. You can also pay for the service either automatically and cancel at any time that you want. It is a fool-proof way of getting professional help, and it’s why a lot of people have put their trust into Talkspace since its inception.

Highland Capital Management partners with George W Bush Presidential Library funding a 10 million dollar endowment

With their gift of 10 million dollars, Highland Capital Management renewed its commitment to the George W. Bush presidential library. The library has distinguished itself in recent years with a variety of public service acts, and the endowment will fund a new series of lectures from authors, thought leaders, and newsmakers. This programming series, “Engage at the Bush Center, presented by Highland Capital Management,” represents a partnership to build a stronger culture of leaders and thinkers.

James Dondero co-founded Highland Capital in 1993, where he grew a reputation for providing intelligent allocation of asset classes and risk management. His team has seen investors through a variety of markets across the world since then, making them a valuable partner for an effective presidential library. Seeing the potential of the library, they had already provided 5 million in funding. Building on the successes achieved, James will join the executive advisory council to help steer the programs aimed at improving schools, libraries, support for vets and even sports teams. Read this article at investopedia.com.

The first event in the new lecture series takes place on Monday, Feb. 5 with a special two-part program in collaboration with the National Constitution Center: “Constitutional Conversations: Justice Scalia’s Memorable Speeches / James Madison & Today’s Media.”

Justice Antonin Scalia’s legacy as a jurist who tirelessly defended the strength of the constitution is the subject of a new book by his son, Christopher Scalia, the first guest in this series. In October of 2017 he published “Scalia Speaks: Reflections on Law, Faith, and Life Well Lived,” and his insights provide the perfect starting point to build on throughout the lecture series. Visit highlandcap.com to know more.

The evening will also feature a panel focusing on how James Madison might view today’s media landscape given his role in crafting the first amendment. Jeffrey Rosen, president and CEO of the National Constitution Center and an expert on Madison; Amy Mitchell, media and social media researcher and co-author of the Pew Research Center’s annual “State of the News Media” report; and Dallas Morning News Editor Mike Wilson. The panel, related to the Bush Institute’s Human Freedom policy work, will be moderated by Amanda Schnetzer, Director of Global Initiatives at the Bush Institute.

Register at bushcenter.org for free admission to hear the conversation with Christopher Scalia and join Highland Capital Management and the George W Bush Presidential Library in their commitment to public service.

Read: https://www.bloomberg.com/news/articles/2017-07-05/highland-is-said-to-buy-lazard-argentine-fund-eye-stock-boost

How Dr. Clay Siegall Built Seattle Genetics From The Ground Up

When founding Seattle Genetics, Dr. Clay Siegall wanted to build a company that would create targeted drug therapies using antibody drug conjugates. He runs the company as its chief executive officer where he handles the strategic vision of the company, forms partnerships with other companies in the pharmaceutical industry, and oversees day to day operations.

Clay has a bachelor’s degree in zoology, acquired at The University of Maryland, and a Ph.D. in genetics that he earned at George Washington University. He was in research and development for a number of years before founding Seattle Genetics in 1998. When he started Seattle Genetics it was running with basically a skeleton crew of fellow researchers. It is now a much bigger company that employs more than 650 people. They also offer fellowships and internships to up and coming researchers, many of them students at the nearby University of Washington.

In order to research their drugs and bring them to market, Dr. Clay Siegall has formed a number of key strategic partnerships. Among these are some of the biggest corporations in the industry such as Pfizer and Bayer. His company has more than 20 drugs under development and one on the market that provides a cure for lymphoma, Adcetris.

Dr. Clay Siegall firmly believes that targeted drug therapies are much safer and more effective than conventional ways of treating cancer. Conventional methods involve surgery, chemotherapy, and radiation which are very harmful to the body. Targeted therapies, on the other hand, seek out and kill only cancerous cells. They leave normal cells completely alone. He’s excited to be playing such an important role in the advance of medicine as we’re increasingly seeing nowadays.

Seattle Genetics makes money a number of ways, Dr. Siegall says. Selling their own proprietary drugs is, of course, the key money maker. They also earn money by forming production partnerships with other firms in the industry. He licenses technology and processes they have created at Seattle Genetics to other companies. He says that creating drugs is a huge risk as only 1 in 10 drugs under development are ever approved. He has formed these partnerships in order to mitigate that.